Published in Helv Med Acta on November 01, 1963
Biosynthesis of vitamin B12: identity of fragment extruded during ring contraction to the corrin macrocycle. Proc Natl Acad Sci U S A (1981) 2.60
Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol (1986) 1.43
A 35-year-old with swollen knees who had recurrent fever and pericarditis, then diarrhoea before getting better. Lancet (1996) 1.42
[Minimally-invasive parathyroidectomy: a good operative procedure for primary hyperparathyroidism even without the use of intraoperative parathyroid-hormone assessment or a gamma probe]. Ned Tijdschr Geneeskd (2005) 1.41
The MELANIE project: from a biopsy to automatic protein map interpretation by computer. Electrophoresis (1991) 1.35
RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci U S A (1984) 1.30
High-sensitivity analysis of neutral underivatized oligosaccharides by nanoelectrospray mass spectrometry. Anal Chem (1997) 1.12
Refractory sideroblastic anemia secondary to autoimmune hemolytic anemia. Acta Haematol (1977) 1.08
Malignant acanthosis nigricans: potential role of chemotherapy. Br J Dermatol (1999) 1.05
Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology (1990) 1.04
Clinical trial: music reduces anxiety levels in patients attending for endoscopy. Aliment Pharmacol Ther (2009) 1.02
Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2002) 1.01
Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia. Pediatrics (1968) 0.99
Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy. Aliment Pharmacol Ther (2001) 0.98
[Influence of aldosterone on the concentration of sodium and chloride in sweat in mucoviscidosis and in the normal subject]. Helv Med Acta (1963) 0.98
Analysis of high-molecular-weight oligosaccharides from human milk by liquid chromatography and MALDI-MS. Anal Chem (1999) 0.98
Clinical course of pain in acute osteoporotic vertebral compression fractures. J Vasc Interv Radiol (2010) 0.98
Proton pump inhibitors and acute interstitial nephritis. BMJ (2010) 0.98
Automatic classification of two-dimensional gel electrophoresis pictures by heuristic clustering analysis: a step toward machine learning. Electrophoresis (1988) 0.94
The adrenocorticotropic action of a new synthetic pentacosapeptide. Experientia (1966) 0.92
Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma. J Lipid Res (1988) 0.90
[Inhibition of plasmatic renin activity by potassium]. J Urol Nephrol (Paris) (1968) 0.90
Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers. Gut (1996) 0.87
Human recombinant interleukin-1 beta and -alpha, but not recombinant tumor necrosis factor alpha stimulate ACTH release from rat anterior pituitary cells in vitro in a prostaglandin E2 and cAMP independent manner. Neuroendocrinology (1988) 0.87
Quantitative studies on the lipolytic response of human subcutaneous and omental adipose tissue to noradrenaline and theophylline. Acta Med Scand (1969) 0.86
Very severe self-poisoning lithium carbonate intoxication causing a myocardial infarction. Chest (1991) 0.86
Exercise capability in heart failure: is cardiac output important after all? Lancet (1991) 0.86
Cerebrospinal fluid sodium concentration and salt appetite. Brain Res (1985) 0.85
Treatment of hyperlipoproteinemia (HLP) type II A with a new phenoxy-isobuturic acid derivative, procetofen. Int J Clin Pharmacol Biopharm (1979) 0.85
Stimulation of fat oxidation, but no sustained reduction of hepatic lipids by prolonged pharmacological inhibition of acetyl CoA carboxylase. Horm Metab Res (2011) 0.85
Relationship between plasma concentrations of angiotensin I, angiotensin II and plasma renin activity during cardio-pulmonary bypass in man. Eur J Clin Invest (1974) 0.83
Sodium appetite in sheep induced by cerebral ventricular infusion of angiotensin: comparison with sodium deficiency. Science (1981) 0.82
Long-term effects of ACTH combined with angiotensin II on steroidogenesis and adrenal zona glomerulosa morphology in the rat. Acta Endocrinol (Copenh) (1987) 0.82
[Maximum gastric stimulation with the augmented histamine test in healthy children]. Helv Paediatr Acta (1969) 0.82
Aldosterone escape to chronic ACTH administration in man. Acta Endocrinol (Copenh) (1983) 0.81
HDL lipids in close relatives of coronary heart disease patients. Environmental and genetic influences. Atherosclerosis (1979) 0.81
Late onset interstitial nephritis associated with mesalazine treatment. BMJ (1998) 0.81
Role of angiotensin in sodium appetite of sodium-deplete sheep. Am J Physiol (1987) 0.81
Effect of nicotinic acid on ACTH and noradrenaline stimulated lipolysis in the rabbit. II. In vitro studies including comparison with prostaglandin E1. Acta Physiol Scand (1970) 0.81
Splenic function, assessed by quantification of erythrocyte membrane pits, is normal in chronic active hepatitis and primary biliary cirrhosis. J Hepatol (1993) 0.81
Dexamethasone treatment increases neuropeptide Y levels in rat hypothalamic neurones. Life Sci (1988) 0.81
Transvaginal electrical stimulation in the treatment of urinary incontinence. BJU Int (2004) 0.81
Analyte incorporation and ionization in matrix-assisted laser desorption/ionization visualized by pH indicator molecular probes. Anal Chem (2001) 0.81
[Inhibition of renin by potassium in the man]. Helv Med Acta Suppl (1967) 0.79
[Interrelations between potassium, renin and aldosterone]. Helv Med Acta Suppl (1966) 0.79
[Hyperkalemic paralysis in an Addison's disease patient under treatment]. Rev Med Suisse Romande (1965) 0.79
"High-resolution" mini-two-dimensional gel electrophoresis automatically run and stained in less than 6 h with small, ready-to-use slab gels. Clin Chem (1988) 0.79
Pressure natriuresis in isolated kidneys from hypertension-prone and hypertension-resistant rats (Dahl rats). Kidney Int (1980) 0.78
Angiotensin II potentiates corticotropin-releasing activity of CRF41 in rat anterior pituitary cells: mechanism of action. Neuroendocrinology (1987) 0.78
High density lipoprotein cholesterol in male relatives of patients with coronary heart disease. Atherosclerosis (1979) 0.78
Effect of volume expansion by hyperosmolar and hyperoncotic solutions under constant infusion of angiotensin II on plasma aldosterone in man and its counterbalance by potassium administration. Eur J Clin Invest (1973) 0.78
Fat mobilizing lipolysis and levels of cyclic AMP in human and dog adipose tissue. Acta Med Scand (1970) 0.78
Comparison of lipolysis in human subcutaneous and omental adipose tissue with regard to effects of noradrenaline, theophylline, prostaglandin E1 and age. Acta Chir Scand (1969) 0.78
Properties of rat anterior pituitary vasopressin receptors: relation to adenylate cyclase and the effect of corticotropin-releasing factor. Proc Natl Acad Sci U S A (1984) 0.77
Amino acids and lipoproteins in plasma of duodenopancreatectomized patients: effects of glucagon in physiological amounts. Eur J Clin Invest (1983) 0.77
Lowered cerebrospinal fluid sodium antagonizes effect of raised blood sodium on salt appetite. Am J Physiol (1983) 0.77
Binding and activation properties of angiotensin II in dispersed rat anterior pituitary cells. Endocrinology (1982) 0.77
[The effect of chlorthalidone (Hygroton) on the urinary elimination of phosphorus and the amount of phosphorus in the blood in hypoparathyroid and normal subjects]. Schweiz Med Wochenschr (1965) 0.77
Renal tubular proteinuria in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol (2005) 0.77
A clinical molecular scanner: the Melanie project. MD Comput (1991) 0.77
There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patients. J Endocrinol Invest (2004) 0.76
Decreased HDL cholesterol in prepubertal and pubertal children of CHD patients. Atherosclerosis (1980) 0.76
[A pregnant woman with autoimmune thyroiditis and recurrent goiter]. Ned Tijdschr Geneeskd (2004) 0.76
Regional distribution of neuropeptide Y-like immunoreactivity in human hypothalamus measured by immunoradiometric assay: possible influence of chronic respiratory failure on tissue levels. Neuroendocrinology (1990) 0.76
Role of sodium concentration of the cerebrospinal fluid in the salt appetite of sheep. Am J Physiol (1982) 0.76
Corticotropin releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin. Life Sci (1988) 0.75
Post-prandial worsening of angina: all due to changes in cardiac output? Br Heart J (1991) 0.75
Long-term management after splenectomy. Hyposplenic patients need prophylactic penicillin. BMJ (1994) 0.75
[HDL and lipoproteins in the families of coronary patients]. Schweiz Med Wochenschr (1981) 0.75
[Coronary atherosclerosis and serum lipoproteins]. Schweiz Med Wochenschr (1979) 0.75
[Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)]. Nouv Presse Med (1980) 0.75
[Kidney and blood pressure regulation]. Verh Dtsch Ges Kreislaufforsch (1967) 0.75
[Influence of hormonal contraception on serum lipoproteins]. Schweiz Med Wochenschr (1978) 0.75
Lipid, lipoprotein and APO-A and APO-B lipoprotein distribution in Italian and Swiss schoolchildren. The Geneva survey. Pediatr Res (1982) 0.75
Summary of Discussion-Session 6. Can Med Assoc J (1964) 0.75
[Diagnosis of Cushing's syndrome with the rapid inhibition test]. Rev Med Suisse Romande (1968) 0.75
[Procetofen in the treatment of hyperlipoproteinaemias (author's transl)]. Schweiz Rundsch Med Prax (1980) 0.75
Anatomical Localization of Corticotropin-Releasing Factor and Arginine Vasopressin in the Human Hypothalamus; the Effect of Corticosteroids on their Concentrations in Human and Rat Hypothalami. J Neuroendocrinol (1990) 0.75
[Predictable, desirable and undesirable effects of the diuretic treatment]. Schweiz Med Wochenschr (1968) 0.75
[Secondary hyperaldosteronism]. Schweiz Med Wochenschr (1968) 0.75
[Adrenocorticotropic action of synthetic polypeptides following suppression of endogenous secretion of ACTH]. Helv Med Acta Suppl (1966) 0.75
[Renal insufficiency and urinary elimination of aldosterone]. Helv Med Acta (1963) 0.75
[ Secondary hyperaldosteronism]. Union Med Can (1968) 0.75
[Factors influencing the rate of elimination of injected fat emulsions (Intralipid) in healthy subjects and in patients with coronary disease]. Schweiz Med Wochenschr (1976) 0.75
[Familial Addison's disease. Adrenocortical insufficiency in 4 brothers, and several probable cases in 2 generations of the same family]. Helv Paediatr Acta (1966) 0.75
[High-density lipoproteins in children with coronary diseases]. Helv Paediatr Acta (1981) 0.75
[Diagnostic importance of sodium and potassium in the sweat during conditions of hypermineralocorticoidism]. Schweiz Med Wochenschr (1968) 0.75
Geneva study on the precursors of atherosclerosis: first results. Soz Praventivmed (1979) 0.75
[Secondary aldosteronism]. Pathol Biol (1968) 0.75
[Low HDL cholesterol in close relatives and patients with myocardial infarct]. Schweiz Med Wochenschr (1978) 0.75
I. Measurement of sweat sodium and potassium excretion for evaluation of mineralocorticoid activity in normal subjects. Helv Med Acta (1969) 0.75
[Study of aldosterone metabolism in a case of congenital nephrogenic diabetes insipidus]. Pediatr Res (1968) 0.75
[A case of juvenile arterial hypertension associated with hypokalemia and low aldosterone secretion (Liddle syndrome)]. Schweiz Med Wochenschr (1968) 0.75
[Distribution of plasma cholesterol in 4 Swiss cities]. Schweiz Med Wochenschr Suppl (1981) 0.75
[Hypokalemia]. Klin Wochenschr (1968) 0.75
[Inhibition of renin by potassium in humans]. Helv Med Acta (1967) 0.75
[Adrenal and extra-adrenal effects of a synthetic polypeptide (Ba 30920) stimulating the adrenal cortex]. Helv Med Acta (1963) 0.75
[Clofibrate--helpful or harmful?]. Schweiz Med Wochenschr (1979) 0.75
[Serum lipoproteins in family members of myocardial infarct victims]. Soz Praventivmed (1978) 0.75